secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-03-12T23:59:59+00:00
Accession:  0001171843-25-001416
Event type: debt
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience enters debt waiver and amendment; substantial doubt about going concern
--------------------------------------------------------------------------------

- Fifth Amendment waives default on net leverage ratio covenant as of Dec 31, 2024; covenant testing suspended through March 31, 2025 if milestones met.
- Revolving credit commitment capped at outstanding amount; interest rate increased to SOFR + 400 bps; monthly amortization payments required.
- Company must achieve refinancing milestones (e.g., term sheet by May 23, 2025) and close refinancing by June 30, 2025.
- Unless refinanced by June 30, 2025, Company states it will be unable to pay debt and fund operations; substantial doubt about going concern.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325001416/0001171843-25-001416-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325001416/f8k_031125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001416

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer